期刊文献+

脂氧素受体激动剂BML-111对左向右分流型肺动脉高压大鼠作用的影响 被引量:1

Effect of lipoxin receptor agonist BML-111 on rats with pulmonary hypertension induced by left-to-right shunt
下载PDF
导出
摘要 目的观察脂氧素受体激动剂BML-111对肺动脉高压大鼠肺动脉压力和肺组织炎症的影响。方法选择SD大鼠30只,随机分为三组:C组、PH组、B组,PH组和B组大鼠行建立左颈总动脉-颈外静脉吻合加左侧股动脉-股静脉吻合,吻合饲养六周后,PH组每天腹腔注射生理盐水,B组每天腹腔注射1mg·kg-1·d-1BML-111连续四周,C组每天腹腔注射等量生理盐水。实验测量指标:平均肺动脉压力、右心室收缩压、RV/(LV+S)、肺小动脉中膜厚度百分比、小动脉肌化程度、新生内膜厚度百分比、肺组织匀浆炎症因子IL-6、TNF-α、MCP-1的水平。结果 PH组和B组平均肺动脉压力、右心室收缩压、RV/(LV+S)、肺小动脉中膜厚度百分比、小动脉肌化程度、新生内膜厚度百分比高于C组(P<0.05),PH组和B组大鼠肺组织匀浆IL-6、TNF-α、MCP-1的含量高于C组(P<0.05);B组平均肺动脉压力、右心室收缩压、肺小动脉中膜厚度百分比、新生内膜厚度百分比低于PH组(P<0.05),B组大鼠肺组织匀浆IL-6、TNF-α、MCP-1均低于PH组(P<0.05)。结论脂氧素受体激动剂BML-111可减轻左向右分流型肺动脉高压大鼠肺动脉压力,其机制可能与减轻肺周围组织炎症反应有关。 Objective To observe the effect of BML-111 on pulmonary arterial pressure and inflammation of rats with pulmonary hypertension induced by left-to-right shunt. Methods Thirty SD rats were randomly divided into three groups: C group, PH group and B group. Both PH group and B group applied left common carotid artery-ex- ternal jugular vein shunt and left femoral artery-vein shunt. Six weeks later, rats in B group received intraperitoneal in- jection of BML-111 1 mg. kg-~. dl, while those in PH group received saline injection for four weeks. The rats in C group were treated by intraperitoneal injection of saline. The MPAP, RVSP, RV/(LV+S), the ratio of media thickness of pulmonary arterioles, distal arteriole muscularization and the count of neointimal proliferation, and the level of IL-6, TNF-ct, MCP-1 of pulmonary tissue were compared between the three groups. Results Compared with C group, the PH ~oup and B group has significantly higher levels of MPAP, RVSP, RV/(LV+S), the ratio of media thickness of pulmonary arterioles, distal arteriole muscularization and the count of neointimal proliferation, and significantly high- er levels of IL-6, TNF-c~, MCP-1 in pulmonary tissue (/~〈0.05). Compared with B group, the PH group has higher levels of MPAP, RVSP, the ratio of media thickness of pulmonary arterioles and the count of neointimal proliferation, IL-6, TNF-a, MCP-1 in pulmonary tissue (P 〈 0.05). Conclusion BML-111 can ameliorate pulmonary arterial hy- pertension. The mechanism might be attributed to the reduction of the inflammation of pulmonary tissue.
出处 《海南医学》 CAS 2013年第2期160-162,共3页 Hainan Medical Journal
基金 十堰市科技局指导项目(编号:ZD20111016)
关键词 BIVIL—111 左向右分流 肺动脉高压 大鼠 BML-111 Left-to-right shunt Pulmonary hypertension Rats
  • 相关文献

参考文献7

  • 1Humbert M, Montani D, Perros F, et al. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle ceils in pulmonary arterial hypertension [J]. Vascul Pharmacol, 2008, 49 (4-6): 113-118.
  • 2Price LC, Wort S J, Perros F, et al. Inflammation in pulmonary arterial hypertension [J]. Chest, 2012, 141(1): 210-221.
  • 3Wu Y, Ye XH, Guo PP, et al. Neuroprotective effect of lipoxin A4 methyl ester in a rat model of permanent focal cerebral ischemia [J]. J Mol Neurosci, 2010, 42(2): 226-234.
  • 4Peskar BM, Ehrlich K, Schuligoi R, et al. Role of lipoxygenases and the lipoxin A(4)/annexin 1 receptor in ischemia-reperfusion-induced gastric mucosal damage in rats [J]. Pharmacology, 2009, 84(5): 294-299.
  • 5Zhang L, Zhang X, Wu P, et al. BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis [J]. Inflamm Res, 2008, 57(4): 157-162.
  • 6Wu SH, Liao PY, Dong L, et al. Signal pathway involved in inhibition by lipoxin A(4) of production of interleukins induced in endothelial cells by lipopolysaccharide [J]. Inflamm Res, 2008, 57 (9): 430-437.
  • 7Gong J, Guo S, Li liB, et al. BML-Ill, a lipoxin receptor agonist, protects haemorrhagic shock-induced acute lung injury in rats [J]. Resuscitation, 2012, 83(7): 907-912.

同被引文献13

  • 1Dorfmuller P, Perros F, Balabanian K, et al. Inflammation in pulmo- nary arterial hypertension [J]. Eur Respir J, 2003, 22(2): 358-363.
  • 2Humbert M, Montani D, Perros F, et al. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pul- monary arterial hypertension [J]. Vascul Pharmacol, 2008, 49(4-6): 113-118.
  • 3Gomez-Arroyo JG, Farkas L, Alhussaini AA, et al. The monocrotaline model of pulmonary hypertension in perspective [J]. Am J Physiol Lung Cell Mol Physiol, 2012, 302(4): 363-369.
  • 4Wang Q, Zuo XR, Wang YY, et al. Monocrotaline-induced pulmo- nary arterial hypertension is attenuated by TNF-alpha antagonists via the suppression of TNF-alpha expression and NF-kappaB path- way in rats [J]. Vaseul Pharmacol, 2012, 58(1-2): 71-77.
  • 5Price LC, Wort SJ, Perros F, et al. Inflammation in pulmonary arteri- al hyrtension [J]. Chest, 2012, 141(1): 210-221.
  • 6Kherbeck N, Tamby MC, Bnssone G, et al. The Role of inflamma- tion and autoimmunity in the pathophysiology of putmonary arterial hypertension [J]. Clin Rev Allergy Immunol, 2011, 44(1): 31-38.
  • 7Sakao S, Tatsumi K, Voelkel NF. Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and tmns- differentiation [J]. Respir Res, 2009, 10(1): 1-10.
  • 8Pinto RF, Higuchi ML, Aiello VD. Decreased numbers of T-lympho- cytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmo- nary hypertension secondary to congenital cardiac shunts [J]. Car- diovasc Pathol, 2004, 13(5): 268-275.
  • 9Roy S, Samanta K, Chakraborti T, et al. Role of TGF-betal and TNF-alpha in IL-lbeta mediated activation of proMMP-9 in pulmo- nary artery smooth muscle cells: involvement of an aprotinin sensi- tive protease [J]. Arch Biochem Biophys, 2011,513(1): 61-69.
  • 10Berger G, Azzam ZS, Hoffrnan R, et al. Coagulation and anticoagu- lation in pulmonary arterial hypertension [J]. Isr Med Assoc J, 2009, 11(6): 376-379.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部